What's new in paraproteinemic demyelinating neuropathy in 2007-2008?
Research and development in the area of paraproteinemic demyelinating peripheral neuropathy is slower than for some of the other inflammatory neuropathy syndromes. However, 2007-2008 has produced developments in the understanding of the pathogenesis of the neuropathy and the paraprotein, a potential new animal model, easier diagnostics, and two randomized controlled trials with the results of others awaited. This short review summarizes these publications.
Lunn
Michael
M
Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK. michael.lunn@uclh.org
D000818:Animals; D002986:Clinical Trials as Topic; D003711:Demyelinating Diseases / Q000276:immunology*; D006801:Humans; D010265:Paraproteinemias / Q000276:immunology*